Alerts will be sent to your verified email
Verify EmailBMLL
|
Bio Medica Laborator
|
Zenotech Laboratorie
|
Shukra Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
43.58 % | 12.1 % | 14.12 % |
|
5yr average Equity Multiplier
|
4.59 | 1.13 | 2.02 |
|
5yr Average Asset Turnover Ratio
|
0.9 | 0.36 | 0.6 |
|
5yr Avg Net Profit Margin
|
14.7 % | -13.89 % | 13.41 % |
|
Price to Book
|
n/a | 2.9 | 13.32 |
|
P/E
|
n/a | 0.0 | 54.3 |
|
5yr Avg Cash Conversion Cycle
|
34.88 Days | -1217.81 Days | -114.74 Days |
|
Inventory Days
|
114.83 Days | 145.01 Days | 40.87 Days |
|
Days Receivable
|
30.75 Days | 61.38 Days | 186.38 Days |
|
Days Payable
|
279.97 Days | 477.06 Days | 342.97 Days |
|
5yr Average Interest Coverage Ratio
|
5.69 | -4.03 | 23.9 |
|
5yr Avg ROCE
|
39.6 % | 9.71 % | 14.63 % |
|
5yr Avg Operating Profit Margin
|
29.22 % | 5.56 % | 20.24 % |
|
5 yr average Debt to Equity
|
2.36 | 0.04 | 0.23 |
|
5yr CAGR Net Profit
|
96.99 % | n/a | 119.04 % |
|
5yr Average Return on Assets
|
13.32 % | 8.4 % | 8.68 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
n/a | 68.84 % | 50.96 % |
|
Share Pledged by Promoters
|
n/a | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
n/a | 0.0 | 0.06 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
n/a | 0.0 | 0.0 |
|
Bio Medica Laborator
|
Zenotech Laboratorie
|
Shukra Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
-
|